RICHMOND, Va. (WRIC) — A new manufacturing process is on track to make developing HIV-prevention medication more affordable and potentially decrease new HIV infections in hard-hit countries. Virginia ...

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...

Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, ...

Hilton Humphries does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...